Zoetis Inc (ZTS)

NYSE
206.31
+1.87(+0.91%)
Pre Market
206.31
0.00(0.00%)
- Real-time Data
  • Volume:
    794,503
  • Bid/Ask:
    204.80/207.21
  • Day's Range:
    204.84 - 206.61

ZTS News

Prev. Close
204.44
Day's Range
204.84-206.61
Revenue
7.41B
Open
205.85
52 wk Range
141.41-210.1
EPS
3.99
Volume
794,503
Market Cap
97.78B
Dividend (Yield)
1.00
(0.49%)
Average Vol. (3m)
1,375,701
P/E Ratio
51.66
Beta
0.63
1-Year Change
29.19%
Shares Outstanding
473,944,193
Next Earnings Date
Nov 04, 2021
What is your sentiment on Zoetis Inc?
or
Market is currently closed. Voting is open during market hours.

Zoetis Inc News

  • Zoetis declares $0.25 dividend
    • BySeeking Alpha-

    Zoetis (NYSE:ZTS) declares $0.25/share quarterly dividend, in line with previous.Forward yield 0.5%Payable Dec. 1; for shareholders of record Oct. 29; ex-div Oct.

  • Jefferies Stick to Their Buy Rating for Zoetis
    • ByInvesting.com-

    Jefferies (NYSE:JEF) analyst David Steinberg maintained a Buy rating on Zoetis (NYSE:ZTS) on Thursday, setting a price target of $235, which is approximately 15.89% above the...

  • 4 Top Healthcare Stocks to Buy in September
    • ByStockNews-

    The ongoing integration of advanced technologies and significant breakthroughs therein, along with rising capital investments and an aging population, make the healthcare...

Zoetis Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsBuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

Zoetis Inc Company Profile

Zoetis Inc Company Profile

Employees
11300

Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.

Read More
  • I bought in after I was offered the stock because I owned Pfizer years ago. My perspective is different because I bought in at a discount when it was under 30 dollars a share. If it takes a dip, I'll just by more. Either way I'm still have a large ROI.
    0
    • Time to offload this stock.  At least 30% decline coming
      2
      • Everything about this company looks good and I've been in with them since January but their price just can't seem to rise to their potential.  Selling off my shares of this boat anchor.
        3
        • Very intresting Stock. Who bought this?
          0
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.